Pharmaceutical - Financial, Vaccines


Current filters:


Popular Filters

Changes to the funding access criteria for some vaccines in New Zealand

Changes to the funding access criteria for some vaccines in New Zealand


New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced changes to the funding…

FinancialHealthcareNew ZealandPharmaceuticalVaccines

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU


The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results


Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule


A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst


While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Russian government to develop domestic production of vaccines


The Russian government is considering investing in the domestic production of vaccines, by building a…


Merck & Co to move HQ as part of cost-savings plan; enters deal with Vaxxas


US pharma giant Merck & Co (NYSE: MRK) is joining a string of drug majors in announcing cost-cutting…

FinancialLicensingMerck & CoPharmaceuticalVaccinesVaxxas

CSL Biotherapies gets US government contract for flu vaccines


CSL Biotherapies, a US subsidiary of Australia's CSL (ASX: CSL), one of the world's leading manufacturers…

CSL BiotherapiesCSL LimitedFinancialNorth AmericaPharmaceuticalProductionVaccines

US government adds $32 million to Bavarian Nordic Imvamune contract


Denmark's Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services…

Bavarian NordicFinancialImvamuneNorth AmericaPharmaceuticalResearchVaccines

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries


The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…


GlaxoSmithKline challenges Argentina court ruling


UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

Stronger incentives for immunization of children in Australia


Australia’s childhood immunization arrangements are to be reformed with the aim of increasing the…


Sanofi oral MS drug Aubagio shows strong efficacy in Ph III trial; plans massive Indian vaccine plant


French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme says that the results of a pivotal…


Emergent BioSolutions gets $1.25 billion BioThrax order for US government


Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Back to top